title: High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study.
abstract: BACKGROUND
  An inconsistent relationship has been reported between insulin and hypertension incidence. Free fatty acids are related to insulin-resistance and may have a direct effect on hypertension. We examined the effect of free fatty acids on hypertension incidence, taking into account other abnormalities of the insulin-resistance syndrome.
  
  
  METHODS
  In all, 2968 non-hypertensive and non-diabetic Caucasian men were followed for 3 years. Hypertension incidence was defined as systolic blood pressure (SBP) > or =160 mmHg or diastolic blood pressure (DBP) > or =95 mmHg or drug treatment for hypertension.
  
  
  RESULTS
  Free fatty acid elevation was a highly significant risk factor for hypertension when controlled for age, family history of hypertension, alcohol consumption, body mass index, iliac circumference and weight change. Further controlling for SBP, heart rate and fasting insulin and glucose did not decrease its predictive power (hazard rate ratio [RR] = 1.58, 95% confidence interval [CI]: 1.30-1.91 comparing the 90th to the 10th percentiles at fasting; RR = 1.54, 95% CI: 1.33-1.79 at 2 h). In a forward stepwise model controlled for age, family history of hypertension, alcohol consumption and SBP, the selected variables explaining the occurrence of hypertension were, in order, weight change, 2-h free fatty acids, iliac circumference and fasting free fatty acids, whereas body mass index, heart rate, insulin, glucose and other lipids did not enter into the model.
  
  
  CONCLUSIONS
  Free fatty acids elevation, when controlled for all known risk factors and other abnormalities of the insulin-resistance syndrome, is a risk factor for hypertension. These results highlight the possible benefits of treatment using free fatty acid oxidation inhibitors.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, Unit 21, Faculty of Medicine Paris-Sud, Villejuif, France.
authors.forename: A
authors.initials: A
authors.lastname: Fagot-Campagna
authors.forename: B
authors.initials: B
authors.lastname: Balkau
authors.forename: D
authors.initials: D
authors.lastname: Simon
authors.forename: J M
authors.initials: JM
authors.lastname: Warnet
authors.forename: J R
authors.initials: JR
authors.lastname: Claude
authors.forename: P
authors.initials: P
authors.lastname: Ducimetière
authors.forename: E
authors.initials: E
authors.lastname: Eschwège
mesh_terms: D000328:Adult; D015986:Confounding Factors, Epidemiologic; D005230:Fatty Acids, Nonesterified / Q000032:analysis*; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D010297:Paris / Q000453:epidemiology; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D005230:Fatty Acids, Nonesterified